Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22058664 | 0.98 | GPR3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL15501448 | 0.98 | GPR3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL25000309 | 0.98 | GPR3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL15501452 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL21108991 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL15501663 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL15501664 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL25645645 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL25645646 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT | |
| SCHEMBL25645685 | 0.97 | PIM3 (0.44) | GPR3CYP1A2MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-10403826-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
| US-20160329502-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-20160329502-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403826-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | GPR3 1285/4885CYP1A2 366/4885MEN1 4702/4885 |
| US-11744151-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | GPR3 1285/4885CYP1A2 366/4885MEN1 4702/4885 |
| US-20160329502-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | GPR3 1285/4885CYP1A2 366/4885MEN1 4702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.